Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, April 16, 2015, 51 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $14.00 to $6,188,242.50.

Highlighted Stocks Traded by Insiders:

Guidewire Software (GWRE) - FREE Research Report

Conway Craig, who is Director at Guidewire Software, sold 1,000 shares at $52.98 on April 16, 2015. Following this transaction, the Director owned 11,414 shares meaning that the stake was reduced by 8.06% with the 1,000-share transaction.

The shares most recently traded at $51.41, down $1.57, or 3.06% since the insider transaction. Historical insider transactions for Guidewire Software go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 5,000
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 14,112
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 146,733

The average volume for Guidewire Software has been 324,900 shares per day over the past 30 days. Guidewire Software has a market cap of $3.7 billion and is part of the technology sector and computer software & services industry. Shares are up 3.75% year-to-date as of the close of trading on Thursday.

Guidewire Software, Inc. provides software products for property and casualty (P&C) insurers. It offers an integrated suite of software applications that address the core processes, such as underwriting and policy administration, claims management, and billing. The company has a P/E ratio of 190.0. Currently, there are 3 analysts who rate Guidewire Software a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on GWRE - FREE

TheStreet Quant Ratings rates Guidewire Software as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Guidewire Software Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Spectra Energy (SE) - FREE Research Report

Buckley Guy G., who is Chief Development Officer at Spectra Energy, sold 1,250 shares at $38.00 on April 16, 2015. Following this transaction, the Chief Development Officer owned 25,521 shares meaning that the stake was reduced by 4.67% with the 1,250-share transaction.

The shares most recently traded at $37.81, down $0.19, or 0.5% since the insider transaction. Historical insider transactions for Spectra Energy go as follows:

  • 4-Week # shares bought: 6,200
  • 4-Week # shares sold: 1,313
  • 12-Week # shares bought: 6,200
  • 12-Week # shares sold: 12,063
  • 24-Week # shares bought: 6,200
  • 24-Week # shares sold: 20,813

The average volume for Spectra Energy has been 4.6 million shares per day over the past 30 days. Spectra Energy has a market cap of $25.7 billion and is part of the basic materials sector and energy industry. Shares are up 5.01% year-to-date as of the close of trading on Thursday.

Spectra Energy Corp, through its subsidiaries, owns and operates a portfolio of natural gas-related energy assets in North America. The stock currently has a dividend yield of 3.87%. The company has a P/E ratio of 23.8. Currently, there are 2 analysts who rate Spectra Energy a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SE - FREE

TheStreet Quant Ratings rates Spectra Energy as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income, expanding profit margins, good cash flow from operations and growth in earnings per share. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Spectra Energy Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Lannett (LCI) - FREE Research Report

Bedrosian Arthur P, who is Ceo at Lannett, sold 5,000 shares at $69.43 on April 16, 2015. Following this transaction, the Ceo owned 621,960 shares meaning that the stake was reduced by 0.8% with the 5,000-share transaction.

The shares most recently traded at $65.34, down $4.09, or 6.26% since the insider transaction. Historical insider transactions for Lannett go as follows:

  • 4-Week # shares bought: 1,250
  • 4-Week # shares sold: 139,635
  • 12-Week # shares bought: 1,250
  • 12-Week # shares sold: 255,351
  • 24-Week # shares bought: 2,750
  • 24-Week # shares sold: 292,851

The average volume for Lannett has been 881,800 shares per day over the past 30 days. Lannett has a market cap of $2.4 billion and is part of the health care sector and drugs industry. Shares are up 56.69% year-to-date as of the close of trading on Thursday.

Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of branded pharmaceutical products in the United States. It offers solid oral, extended release, topical, and oral solution finished dosage forms of drugs that address a range of therapeutic areas. The company has a P/E ratio of 19.6. Currently, there are 2 analysts who rate Lannett a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on LCI - FREE

TheStreet Quant Ratings rates Lannett as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, attractive valuation levels and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Lannett Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Data for this article provided by Zacks Investment Research

null